Efficient replication systems for hepatitis C virus using a new human hepatoma cell line

Area of Science:

• Hepatology
• Virology
• Cell Biology

Background:

• Persistent hepatitis C virus (HCV) infection is a global health concern causing chronic liver disease.
• Existing HCV research relies on cell culture systems for RNA replication and virus production, primarily in HuH-7 cells.
• A need exists for alternative cell lines to advance HCV research and therapeutic development.

Purpose of the Study:

• To identify and characterize a novel human hepatoma cell line for persistent HCV production.
• To establish and validate HCV replication and production systems in this new cell line.
• To assess the utility of the new cell line for anti-HCV reagent screening.

Main Methods:

• Screening of human hepatoma cell lines for HCV susceptibility and persistent production.
• Development of HCV RNA replicons and genome-length replicating systems with adaptive mutations.
• Infectious HCV production assays using the novel cell line.
• Comparative analysis of cDNA expression profiles between Li23 and HuH-7 cells.

Main Results:

• A new human hepatoma cell line, Li23, was identified that supports persistent HCV production.
• Li23 cells demonstrated distinct cDNA expression profiles compared to HuH-7 cells, despite similar liver-specific expression.
• Established HCV replication and production systems, including a reporter assay, were functional in Li23-derived cells.
• Li23-derived cells persistently produced infectious HCV of a specific strain.

Conclusions:

• The Li23 cell line offers a new platform for persistent HCV production and anti-HCV drug screening.
• This cell line provides a valuable tool for studying the HCV life cycle and identifying novel antiviral targets.
• Li23 expands the available cellular models for hepatitis C virus research.